A client is receiving verteporfin treatment for macular degeneration. The client asks the nurse what the expected outcome of treatment is. Which response by the nurse is most appropriate?

Question

Quizplus · Accepted Answer

A)One treatment for macular degeneration is the use of verteporfin, a drug that tends to adhere to the surface of new blood vessels. This medication is injected systemically. Light is then shined into the affected eye, activating the drug and destroying new blood vessels. The best outcome for this treatment is that it will slow the disease. This does not reverse the symptoms of the disease. New vessel growth is not desirable. The client's condition will be slowed at best; it is not likely to improve. Surgical therapy is rare as a treatment for AMD and this medication does not improve the efficacy of surgery.
B)One treatment for macular degeneration is the use of verteporfin, a drug that tends to adhere to the surface of new blood vessels. This medication is injected systemically. Light is then shined into the affected eye, activating the drug and destroying new blood vessels. The best outcome for this treatment is that it will slow the disease. This treatment is relatively fast and painless, but that is not the best outcome the client may expect. New vessels continuing to grow is a risk of the treatment. The client's condition will be slowed at best; it is not likely to improve. Surgical therapy is rare as a treatment for AMD.
C)One treatment for macular degeneration is the use of verteporfin, a drug that tends to adhere to the surface of new blood vessels. This medication is injected systemically. Light is then shined into the affected eye, activating the drug and destroying new blood vessels. The best outcome for this treatment is that it will slow the disease. This treatment is relatively fast and painless, but that is not the best outcome the client may expect. New vessels continuing to grow is a risk of the treatment. The client's condition will be slowed at best; it is not likely to improve. Surgical therapy is rare as a treatment for AMD.
D)One treatment for macular degeneration is the use of verteporfin, a drug that tends to adhere to the surface of new blood vessels. This medication is injected systemically. Light is then shined into the affected eye, activating the drug and destroying new blood vessels. The best outcome for this treatment is that it will slow the disease. This treatment is relatively fast and painless, but that is not the best outcome the client may expect. New vessels continuing to grow is a risk of the treatment. The client's condition will be slowed at best; it is not likely to improve. Surgical therapy is rare as a treatment for AMD.

A Client Is Receiving Verteporfin Treatment for Macular Degeneration